Steris stock edges lower after a $2.59 EPS beat

Steris stock is under pressure after August 5, 2026 results showed $2.59 EPS on $1.49 billion of revenue, while the market cap stood at $22.71 billion on August 28, 2026.

Steris plc (IE00BFY8C754) stock opened at $232.91 on August 28, 2026, with a market cap of $22.71 billion and a 1-year range of $195.14 to $269.44. The latest quarterly report, announced on August 5, 2026, showed earnings per share of $2.59 on revenue of $1.49 billion.

August results still matter

The August 5 quarter was the freshest reported fundamental anchor in the source set, and it gave investors a clean comparison point: EPS rose from $2.34 a year earlier to $2.59, while revenue increased 7.3% year over year. Revenue also matched the consensus estimate of $1.49 billion, so the surprise came from profit rather than sales.

That mix is important because the stock's valuation already reflected solid execution, with a P/E ratio of 28.47 in the same market snapshot. For investors, the key question is whether margin stability can keep pace with a business that is still growing, but not by a huge amount.

What the market is pricing

Return on equity stood at 14.34% and net margin was 13.34% in the same quarterly snapshot, giving a second layer of context behind the headline EPS beat. Analysts also projected full-year EPS of 11.09, which frames the August quarter as one part of a larger earnings path rather than a one-off move.

A 1-year high of $269.44 is still visible above the opening price, while the low of $195.14 shows the stock has already absorbed a wide trading band in 2026. The gap between those levels and the current quote leaves room for the market to keep reacting to each earnings update.

STERIS's sterilization systems

STERIS's sterilization and contamination-control systems remain central to the company's medical equipment franchise, and the quarter's revenue and EPS figures show that demand is still translating into earnings power. The business model benefits from recurring healthcare and life-sciences spending, which makes the margin profile especially important when revenue growth stays in single digits.

Price and trading view

STERIS stock traded at $232.91 on August 28, 2026, against a market value of $22.71 billion. The 1-year range of $195.14 to $269.44 keeps the current price in the middle of the yearlong band.

More on STERIS plc

Company: STERIS plc
ISIN: IE00BFY8C754
Ticker: STE
Exchange: NYSE
Sector / Industry: Health Care / Medical Instruments & Supplies
Index membership: S&P 500